These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8864166)

  • 1. Toxicokinetic analysis of losartan during gestation and lactation in the rat.
    Spence SG; Zacchei AG; Lee LL; Baldwin CL; Berna RA; Mattson BA; Eydelloth RS
    Teratology; 1996 Apr; 53(4):245-52. PubMed ID: 8864166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats.
    Spence SG; Allen HL; Cukierski MA; Manson JM; Robertson RT; Eydelloth RS
    Teratology; 1995 Jun; 51(6):367-82. PubMed ID: 7502237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the reproductive and developmental toxicity of the AT1-selective angiotensin II receptor antagonist losartan in rats.
    Spence SG; Cukierski MA; Manson JM; Robertson RT; Eydelloth RS
    Teratology; 1995 Jun; 51(6):383-97. PubMed ID: 7502238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats.
    Weisenburger WP; Hagler AR; Tassinari MS
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):171-84. PubMed ID: 15282738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two generation reproduction study of ethylbenzene by inhalation in Crl-CD rats.
    Faber WD; Roberts LS; Stump DG; Tardif R; Krishnan K; Tort M; Dimond S; Dutton D; Moran E; Lawrence W
    Birth Defects Res B Dev Reprod Toxicol; 2006 Feb; 77(1):10-21. PubMed ID: 16342202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical pharmacology of losartan in Japanese subjects and patients.
    Nakashima M; Umemura K
    Blood Press Suppl; 1996; 2():62-6. PubMed ID: 8913542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive safety studies with genistein in rats.
    McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
    Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.
    Lo MW; Goldberg MR; McCrea JB; Lu H; Furtek CI; Bjornsson TD
    Clin Pharmacol Ther; 1995 Dec; 58(6):641-9. PubMed ID: 8529329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR; Cukierski MA; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation developmental neurotoxicity study of ethylbenzene in Crl-CD rats.
    Faber WD; Roberts LS; Stump DG; Beck M; Kirkpatrick D; Regan KS; Tort M; Moran E; Banton M
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):34-48. PubMed ID: 17294454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining the effects observed in a developmental neurobehavioral study of ammonium perchlorate administered orally in drinking water to rats. I. Thyroid and reproductive effects.
    York RG; Lewis E; Brown WR; Girard MF; Mattie DR; Funk KA; Strawson JS
    Int J Toxicol; 2005; 24(6):403-18. PubMed ID: 16393933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monomethylarsonic acid and dimethylarsinic acid: developmental toxicity studies with risk assessment.
    Irvine L; Boyer IJ; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2006 Feb; 77(1):53-68. PubMed ID: 16496296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
    Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
    Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vivo effects of irbesartan and losartan on angiotensin II receptor binding in the rat kidney following oral administration.
    Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
    Clin Sci (Lond); 2000 Oct; 99(4):331-41. PubMed ID: 10995600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular number and size following chronic angiotensin II blockade in the postnatal rat.
    McCausland JE; Bertram JF; Ryan GB; Alcorn D
    Exp Nephrol; 1997; 5(3):201-9. PubMed ID: 9208279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.